Centessa Pharmaceuticals Statistics

Total Valuation

CNTA has a market cap or net worth of $4.37 billion. The enterprise value is $4.24 billion.

Market Cap	4.37B
Enterprise Value	4.24B

Important Dates

The last earnings date was Wednesday, November 5, 2025, before market open.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

CNTA has 146.08 million shares outstanding. The number of shares has increased by 25.82% in one year.

Current Share Class	n/a
Shares Outstanding	146.08M
Shares Change (YoY)	+25.82%
Shares Change (QoQ)	+0.36%
Owned by Insiders (%)	0.64%
Owned by Institutions (%)	46.57%
Float	87.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	265.73
Forward PS	n/a
PB Ratio	13.33
P/TBV Ratio	14.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	282.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.57, with a Debt / Equity ratio of 0.39.

Current Ratio	10.57
Quick Ratio	10.25
Debt / Equity	0.39
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-19.21

Financial Efficiency

Return on equity (ROE) is -60.62% and return on invested capital (ROIC) is -26.63%.

Return on Equity (ROE)	-60.62%
Return on Assets (ROA)	-25.26%
Return on Invested Capital (ROIC)	-26.63%
Return on Capital Employed (ROCE)	-51.00%
Revenue Per Employee	$194,805
Profits Per Employee	-$3.15M
Employee Count	77
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

In the past 12 months, CNTA has paid $3.39 million in taxes.

Income Tax	3.39M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +74.30% in the last 52 weeks. The beta is 1.56, so CNTA's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	+74.30%
50-Day Moving Average	24.98
200-Day Moving Average	17.66
Relative Strength Index (RSI)	69.54
Average Volume (20 Days)	2,090,022

Short Selling Information

Short Interest	5.92M
Short Previous Month	5.15M
Short % of Shares Out	4.64%
Short % of Float	n/a
Short Ratio (days to cover)	3.36

Income Statement

In the last 12 months, CNTA had revenue of $15.00 million and -$242.70 million in losses. Loss per share was -$1.82.

Revenue	15.00M
Gross Profit	15.00M
Operating Income	-213.80M
Pretax Income	-239.31M
Net Income	-242.70M
EBITDA	-213.49M
EBIT	-213.80M
Loss Per Share	-$1.82

Full Income Statement

Balance Sheet

The company has $246.21 million in cash and $118.26 million in debt, giving a net cash position of $127.96 million or $0.88 per share.

Cash & Cash Equivalents	246.21M
Total Debt	118.26M
Net Cash	127.96M
Net Cash Per Share	$0.88
Equity (Book Value)	301.57M
Book Value Per Share	2.24
Working Capital	278.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$180.81 million and capital expenditures -$360,000, giving a free cash flow of -$181.17 million.

Operating Cash Flow	-180.81M
Capital Expenditures	-360,000
Free Cash Flow	-181.17M
FCF Per Share	-$1.24

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,425.33%
Pretax Margin	-1,595.38%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CNTA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.82%
Shareholder Yield	-25.82%
Earnings Yield	-5.55%
FCF Yield	-4.15%

Analyst Forecast

The average price target for CNTA is $35.00, which is 17.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$35.00
Price Target Difference	17.02%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CNTA has an Altman Z-Score of 4.29 and a Piotroski F-Score of 2.

Altman Z-Score	4.29
Piotroski F-Score	2